McKinsey, JPMorgan Chase drop Purdue Pharma amid opioid scrutiny Posted by: Stonecom Interactive Friday, May 24, 2019 Companies are distancing themselves from the Oxycontin maker and its founding family amid thousands of lawsuits Source 2019-05-24 Stonecom Interactive